This course is FREE with Unlimited CE!

Choose from two Unlimited CE subscription options and get access to 750+ CE and professional development courses.

Get access starting at $49.95/yrLoading..

Goal and Learning Outcomes

Despite recent improvements in patient access to medical care in the U.S., diabetic foot ulcers continue to be a prevalent health problem. Understanding the pathophysiology of diabetic ulcers enhances screening and prevention skills and assessment of current wounds. Treatment requires participation of a multidisciplinary healthcare team to ensure appropriate wound care, monitoring, and ongoing reassessment to prevent recurrence.
 
The goal of this course is to provide physicians, physician assistants, nurses, certified diabetes educators, and radiology professionals in acute care settings with information regarding the development, prevention, and care of diabetic foot ulcers.

Course Authors

4.7 Average

Course Reviews

293 reviews

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.